Ligand Pharma (LGND) Tops Q2 EPS by 29c
Tweet
Share
E-mailGet Alerts LGND Hot Sheet
Price: $288.46 -1.13%
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Financial Fact:
Income (loss) before income taxes: 1.21M
Today's EPS Names:
SCWO, HSAI, SYRS, More
Join SI Premium – FREE
Ligand Pharma (NASDAQ: LGND) reported Q2 EPS of $1.63, $0.29 better than the analyst estimate of $1.34. Revenue for the quarter came in at $54.7 million versus the consensus estimate of $70.41 million.
For earnings history and earnings-related data on Ligand Pharma (LGND) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Klarna shares tumble on weak full-year revenue guidance
- Hesai Group (HSAI) Tops Q1 EPS by 8c
- Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
